Table 5.
Findings related to medications of the 687 patients with clinical relevance for their subjective complaints
| Relevant medication-related finding1 | Frequency (%)2 |
|---|---|
| No relevant medication-related finding | 79.0 |
| Antihypertensives (e.g., beta-blockers, calcium antagonists, renin-angiotensin system inhibitors) | 10.0 |
| Psychotropic drugs (antidepressants, antipsychotics) | 5.7 |
| Antilipidemics (statins) | 2.3 |
| Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs) | 1.3 |
| Broncholytic anti-asthmatic drugs | 1.3 |
| Gastrointestinal drugs | 1.3 |
| Diuretics | 1.2 |
| Urologic drugs | 1.0 |
| Gout drugs | 0.7 |
| Hypnotics, sedatives | 0.7 |
| Sexual hormones and their inhibitors | 0.7 |
| Antidiabetics | 0.4 |
| Anticonvulsants | 0.4 |
| Parkinson’s disease drugs and other drugs for extrapyramidal disorders | 0.4 |
1Relevant medication-related findings in at least 3 patients (0.4% of the 687 patients) are listed
2100% = 687 patients, multiple entries per patient were possible. Five hundred forty-three patients (79.0%) exhibited no medication-related finding. Ninety-four patients (13.7%) had one relevant finding, 36 patients (5.2%) had two, 10 patients (1.5%) three, 3 patients (0.4%) four, and one patient (0.1%) five relevant findings